- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
Dow Agrosciences introduces genetically modified corn seed
July 27, 2009
IBJ StaffEven after a string of acquisitions, Dow AgroSciences is a bit player in the seed business. But the new genetically
modified corn it developed with St. Louis-based giant Monsanto Co. finally provides the breakthrough product that could grow
its seed sales substantially.
MorePotential obesity breakthrough boosts Marcadia
July 20, 2009
J.K. WallFavorable article in prestigious journal could draw attention to Carmel biotech startup.
MoreProfessors go online to revolutionize drug discovery
July 20, 2009
IBJ StaffTwo chemistry professors at IUPUI are laboring to create the McDonald’s of research laboratories—low-cost and
all over the world.
MoreLilly cancer drug OK'd for new use
July 6, 2009
J.K. WallEli Lilly and Co.'s top rising-star drug has been approved by U.S. regulators for a new use, an event that could boost sales
of
the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer
for certain patients, Lilly announced today.
MoreMinority suppliers diversifying into life sciences
July 6, 2009
Scott OlsonThe Indiana Minority Supplier Development Council has made life sciences companies its latest target—part of an even
larger effort to attract minorities to the burgeoning life sciences industry under
way on a national scale.
MoreBoard battle brewing at Bioanalytical
June 29, 2009
IBJ StaffWest Lafayette-based life sciences contract research firm Bioanalytical Systems Inc. has five directors on its board. If company
founder Pete Kissinger has his way, four of them will soon be replaced.
MoreProfs trying to revolutionize drug discovery process
June 22, 2009
IBJ StaffTwo chemistry professors at IUPUI are laboring to create the McDonald's of research laboratories—a model that's low-cost
and can spread around the world.
MoreBioanalytical Systems founder fights to be heard
May 4, 2009
Peter SchnitzlerIt took Pete and Candace Kissinger 33 years to build West Lafayette-based Bioanalytical Systems Inc. into one of the largest
contract research firms in Indiana's life science sector. It took just a year and a half for them to turn against the company's
new management.
MoreWith pharma famine looming, Lilly relying on snack-size deals
May 4, 2009
J.K. WallCompared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using
a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year,
Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.
MoreStem cell discovery promises health care revolution
April 13, 2009
Bloomberg NewsScientists are using a new stem-cell technique that may someday revolutionize care for disorders as diverse as diabetes, Alzheimer's
disease and muscular dystrophy.
MoreIndiana playing trailblazing role in drive to tailor pharmaceuticals to genetic makeup of individuals
April 13, 2009
Chris O'MalleyIndiana is becoming not only a hotbed of "pharmacogenomics" research, but also a trailblazer in finding practical ways to
use it on the practitioner level.
MoreLinking specialties is key to life sciences
March 30, 2009
The Indiana Innovation Alliance will bring together researchers from both IU and Purdue and keep much intellectual property
innovation in Indiana.
MoreExecutives make many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cells
March 23, 2009
J.K. WallEli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made
from cells.
MoreMedical, tech entrepreneurs launch matchmaking effort in life sciences
March 16, 2009
Chris O'MalleyThree entrepreneurs from the medical and software realms are herding angels to invest in upstart life sciences companies in
Indiana.
MoreAttorneys with doctorates in high demand
March 16, 2009
Scott OlsonLawyers holding doctorates in biotech, biology, chemistry and computer sciences are in high demand by firms with strong intellectual
property practices.
MoreDow may need to sell Indy's Dow AgroSciences
February 16, 2009
Peter SchnitzlerFinancially strapped Dow Chemical Co. acknowledges it may sell Indianapolis-based Dow AgroSciences LLC, the ag-chemicals-and-biotech
firm that's one of the biggest jewels in the city's life sciences crown.
MoreAdvanced energy next focus for economic development
February 16, 2009
Chris O'MalleyThe Central Indiana Corporate Partnership—the parent of the BioCrossroads, TechPoint and Conexus industry cluster initiatives—let
it be known last month that there would be a fourth leg to its economic development stool: clean technology.
MoreNASA contracts soaring
February 9, 2009
Chris O'MalleyNASA begins to award more grants to Indiana firms and universities.
MoreBiotech push may help offset generic competition; some analysts skeptical
February 2, 2009
J.K. WallLilly executives want to make biotech their top focus.
MoreCarmel startup lands $12M in venture capital
January 19, 2009
Peter SchnitzlerCarmel startup Waterstone Pharmaceuticals Inc., which hopes to research drug components here and make them in China, has just
raised $12 million in venture
capital—despite the recession and a deep freeze in financial markets.
MoreOBS Medical hopes to capture pharma's heart
January 19, 2009
J.K. WallThe latest product to come out of Carmel-based OBS Medical may be just what the doctors ordered. The doctors working for major
pharmaceutical companies, that is.
MoreGrants will shrink, life sciences leader predicts
January 19, 2009
Scott OlsonLast fall, BioCrossroads named Leonard J. Betley—chairman of the Richard M. Fairbanks Foundation, the Regenstrief Foundation
and the Walther Cancer Foundation—its inaugural Life Sciences Champion of the Year. IBJ
recently caught up with Betley to get his thoughts on the latest life sciences developments and gauge the climate
for fund raising.
MoreTarganta receives rescue line for drug
January 19, 2009
A former Eli Lilly and Co. antibiotic being developed in Indianapolis will live to try again. The company developing the drug,
Massachusetts-based Targanta Therapeutics Inc., has agreed to be acquired by New Jersey-based
The Medicines Co. for $42 million.
MoreState's tech sector looking ahead, but cutting back
January 12, 2009
It's two steps forward, one step back, for Indiana's technology sector, but in a tough economic climate, any advancement is
worth celebrating.
MoreBiotech venture fund in works
January 5, 2009
Peter SchnitzlerBioCrossroads is setting the stage to create Indiana Future Fund II, an effort that would raise tens of millions of dollars
for speculation on promising Hoosier life science companies.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Laura-the festivals and tastings are free. What does is strengthen the sense of community with activities. What are those empty lots doing for the Village? it's sad you can't see the good that this progress can do for the area. No one is requiring anyone to shop there. I guess you'd rather see a Dollar store move in or no, we'd rather see the property stand empty b/c change is out of the question.
Read down to the part about Brizzi. Someone needs to subpoena his "purchases" of Red RockPictures and Cellstar and his corresponding bank records, I mean c'mon, I'd like to see his alcohol usage records, too. http://diana-vice.blogspot.com/2011_01_01_archive.html
Wonder if my neighborhood can advertise our "retention" pond and act like it is a beach too?
a new record at the '11 salebration until they realized that it was a futile effort to get their crapwagon moter and crapwagon car up speed. And then they just quietly slunk off into the night and never spoke of it again. Nothing to see here folks.
millions for putting a company's bumper sticker on one of its Lolas. But you gotta take what you can get.